134 related articles for article (PubMed ID: 6160106)
1. Protective effects of S-sulfonated human gamma globulin against experimental infections in mice.
Tomioka H; Iwamura Y; Suzuki Y; Ohtomo S; Hashimoto Y
Infect Immun; 1980 Nov; 30(2):329-36. PubMed ID: 6160106
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of human gamma-globulin preparation in experimental pseudomonas aeruginosa infections in mice and its mode of action.
Kamimura T
Arzneimittelforschung; 1984; 34(11):1528-34. PubMed ID: 6084512
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of human gamma-globulin preparations against experimental aerosol infections of mice with Bordetella pertussis.
Imaizumi A; Suzuki Y; Sato H; Sato Y
Vox Sang; 1985; 48(1):18-25. PubMed ID: 2578698
[TBL] [Abstract][Full Text] [Related]
4. A polyvalent human gamma-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection.
Fisher MW
J Infect Dis; 1977 Aug; 136 Suppl():S181-5. PubMed ID: 70492
[TBL] [Abstract][Full Text] [Related]
5. [Synergism of ciprofloxacin with beta-lactam antibiotics, gentamicin, minocycline and pipemidic acid].
Dickgiesser N; in der Stroth S; Wundt W
Infection; 1986; 14(2):82-5. PubMed ID: 2940188
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
Beskid G; Siebelist J; McGarry CM; Cleeland R; Chan K; Keith DD
Chemotherapy; 1990; 36(2):109-16. PubMed ID: 2107064
[TBL] [Abstract][Full Text] [Related]
8. [Studies on human gamma-globulin of placental origin. II. Experiments on antibacterial effect].
Hein H
Arzneimittelforschung; 1965 Jul; 15(7):785-96. PubMed ID: 4159769
[No Abstract] [Full Text] [Related]
9. Clinical trial of sulfonated immunoglobulin preparation for intravenous administration. I. Replacement therapy for primary immunodeficiency syndromes.
Kobayashi N; Gohya N; Matsumoto S
Eur J Pediatr; 1981 May; 136(2):159-65. PubMed ID: 6164554
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine.
Matsumoto K; Otani T; Une T; Osada Y; Ogawa H; Azuma I
Infect Immun; 1983 Mar; 39(3):1029-40. PubMed ID: 6341226
[TBL] [Abstract][Full Text] [Related]
11. Anti-gamma globulins and chronic infection: comparative studies of the immune response to various bacteria and gamma globulin preparations.
Williams RC; Mellbye OJ; Kronvall G
Infect Immun; 1972 Sep; 6(3):316-23. PubMed ID: 4404684
[TBL] [Abstract][Full Text] [Related]
12. The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model.
Gudmundsson S; Einarsson S; Erlendsdottir H; Moffat J; Bayer W; Craig WA
J Antimicrob Chemother; 1993 May; 31 Suppl D():177-91. PubMed ID: 8335520
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
[TBL] [Abstract][Full Text] [Related]
14. [Effects of human gamma globulin preparations and monoclonal antibody on the whole blood chemiluminescence response].
Tsuji A; Asahara M; Aoki Y; Kitaya S; Ohono A; Goto S; Kaneko H
Kansenshogaku Zasshi; 1987 Sep; 61(9):1015-22. PubMed ID: 2450934
[No Abstract] [Full Text] [Related]
15. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
17. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
18. Effect of gamma-globulin preparations on phagocytic function of whole blood.
Tono-Oka T; Matsumoto T; Imai K; Matsumoto S
Biomed Pharmacother; 1985; 39(9-10):477-81. PubMed ID: 2421798
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of cefpirome, a new cephalosporin, on various models of infections in mice and rats.
Arai S; Kobayashi S; Hayashi S
Jpn J Antibiot; 1990 Jan; 43(1):1-8. PubMed ID: 2190011
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
